Monize Medical Group

1216 SE 1st Ave, Fort Lauderdale, FL, 33316

What we can verify

Each claim below is backed by a source we checked. Claims we couldn’t evidence are simply absent, which does not mean the clinic doesn’t offer them.

Semaglutide

confidence 0.90

“One of our key tools is semaglutide, a groundbreaking medication recently approved by the FDA for weight management (brand names: Ozempic, Wegovy, Rybelsus).”

Clinic website — monizemedical.com/semaglutide-weight-loss-fort-lauderdale/ • checked 2026-09-17

GLP-1 care

confidence 0.90

“Semaglutide (brand name: Ozempic, Wegovy, Rybelsus) is a glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking a natural gut hormone.”

Clinic website — monizemedical.com/semaglutide-weight-loss-fort-lauderdale/ • checked 2026-09-17

Weight management

confidence 0.90

“Achieve lasting weight loss at Monize Medical. Our program goes beyond restrictive diets and surgery, addressing the hormonal causes of weight gain with personalized plans featuring semaglutide, a groundbreaking FDA-approved medication.”

Clinic website — monizemedical.com/ • checked 2026-09-17

Direct Primary Care

confidence 0.95

“Listed as a pure direct primary care practice.”

DPC Frontier — mapper.dpcfrontier.com/practice/zmfmqpyieiub • checked 2026-09-17

Clinicians

Name	Specialty	Panel	NPI
Brian Monize, DO	Internal Medicine, Endocrinology, Diabetes & Metabolism	—	1144596057NPI record verified

An NPI is a registry identifier. Per NPPES, holding one does not establish that a provider is licensed or credentialed. Verify licensure with the relevant state medical or nursing board.

More in Fort Lauderdale

Listing checked September 17, 2026. How we verify listings

GLP-1 Care Map lists providers and patient-reported information. It is not medical advice and does not recommend any provider or treatment. We do not verify licensure, and services and prices change: confirm details with the provider before you book.